Skip to main content
SpringerLink
Log in

Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

The interaction between metastasizing tumor cells and the hemostatic system of the host has been implicated in successful tumor cell dissemination. Prostacyclin (PGI2) decreases metastasis from tail vein injected B16 amelanotic melanoma (B16a) cells when administered 15 min prior to tumor cells. This effect is potentiated by a phosphodiesterase inhibitor. Initial trapping of 125I Udr labelled tumor cells in pulmonary vascular beds is unaltered by PGI2 but retention time is decreased. PGI2 decreases retention time even when administered 60 min post tumor cells. Structurally unrelated thromboxane (TX) synthetase inhibitors and a TXA2 receptor antagonist also reduce metastasis from tail vein injected B16a cells. Furthermore, one inhibitor, 1-(7-carboxyheptyl)imidazole, when injected intraperitoneally reduced spontaneous metastasis from subcutaneous B16a and Lewis lung carcinoma tumors. These results suggest that selective manipulation of PGI2 and TXA2 can reduce the hematogenous spread of tumor cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bastida, E., Ordinas, A., and Jamieson, G. A., 1981, Idiosyncratic platelet responses to human tumour cells. Nature, (London), 291, 661–662.

    Google Scholar 

  2. Brain, M. C., Azzopardi, J. G., Baker, L. R. I., Pinco, G. F., Roberts, P. D., and Dacic, J. V., 1970, Microangiopathic haemolytic anemia: the possible role of vascular lesion in pathogenesis. British Journal of Haematology, 18, 183–190.

    Google Scholar 

  3. Carreras, L. O., Chamone, D. A. F., Klercky, P., and Vermylen, J., 1980, Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound Bay g 6575. Thrombosis Research, 19, 663–671.

    Google Scholar 

  4. Curatolo, L., Colucci, M., Cambini, A. L., Poggi, A., Morasca, L., Donati, M. B., and Serjeraro, N., 1979, Evidence that cells from experimental tumours can activate coagulation factor X. British Journal of Cancer, 40, 228–233.

    Google Scholar 

  5. Donati, M. B., Davidson, J. F., and Carattini, S., 1981, Malignancy and the Hemostatic System (New York: Raven Press), pp. 138.

    Google Scholar 

  6. Donati, M. B., and Poggi, A., 1980, Malignancy and haemostasis. British Journal of Haematology, 44, 173–182.

    Google Scholar 

  7. Dvorak, H. F., Quay, S. C., Orenstein, N. R., Dvorak, A. M., Hahn, P., and Bitzer, A. M., 1981, Tumor shedding and coagulation. Science, 212, 923–924.

    Google Scholar 

  8. Elias, E. G., Sepulveda, F., and Mink, I. B., 1973, Increasing the efficiency of cancer chemotherpy with heparin: Clinical study. Journal of Surgical Oncology, 5, 189–193.

    Google Scholar 

  9. [9]Fling, T. E., Honn, K. V., Busse, W. D., Suter, F., and Marnett, L. J., 1982, Stimulation of PGI2 biosynthesis by nafazatrom (Bay g 6575). Prostaglandins and Cancer, edited by T. J. Powles, R. S. Bockman, K. V. Honn and P. W. Ramwell (New York: Alan Liss, Inc.), pp. 783–788.

    Google Scholar 

  10. Fantone, J., Kunkel, S., and Varani, J., 1982, Inhibition of tumor cell adherence by prostaglandins. Prostaglandins and Cancer, edited by T. J. Powles, R. S. Bockman, K. V. Honn and P. W. Ramwell (New York: Alan Liss, Inc.), pp. 673–678.

    Google Scholar 

  11. Fidler, I. J., 1978, General considerations for the studies of experimental cancer metastases. Methods of Cancer Research, 25, 399–439.

    Google Scholar 

  12. Fitzpatrick, F. A., Bundy, G. L., Gorman, R. R., and Honohan, R., 1978, 9,11-Epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets. Nature, (London), 275, 765–766.

    Google Scholar 

  13. Fitzpatrick, F. A., Bundy, G. L., Gorman, R. R., Honahan, R., McGuire, J., and Sun, F., 1979, 9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor. Biochimica et biophysica acta, 573, 238–244.

    Google Scholar 

  14. Fitzpatrick, F. A., and Gorman, R. R., 1978, A comparison of imidazole and 9,11azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors. Biochimica et biophysica acta, 539, 162–172.

    Google Scholar 

  15. Fulco, G., Granstrom, E., and Kindahl, H., 1977, Albumin stabilizes thromboxane A2. FEBS Letters, 82, 321–326.

    Google Scholar 

  16. Gasic, G. J., Boettiger, D., Catalfamo, J. L., Gasic, T. B., and Stewart, G. J., 1978, Aggregation of platelets and cell membrane vesiculation by rat cells transformed in vitro by Rous Sarcoma virus. Cancer Research, 38, 2950–2955.

    Google Scholar 

  17. Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T., and Murphy, S., 1973, Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. International Journal of Cancer, 11, 704–718.

    Google Scholar 

  18. Gasic, G. J., Gasic, T. B., and Jimenez, S. A., 1977, Platelet aggregating material in mouse tumor cells. Laboratory Investigation, 36, 413–419.

    Google Scholar 

  19. [19]Gasic, G. J., Gasic, T. B., and Stewart, C. C., 1968, Antimetastatic effects associated with platelet reduction. Proceedings of the National Academy of Sciences of the United States of America, 61, 46–52.

    Google Scholar 

  20. Gastpar, H., 1977, Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approach to metastasis prophylaxis. Journal of Medicine (Westbury, New York), 8, 103–114.

    Google Scholar 

  21. Gordon, S. G., and Cross, B. A., 1981, A factor X-activating cysteine protease from malignant tissue. Journal of Clinical Investigation, 67, 1665–1671.

    Google Scholar 

  22. Gordon, S. G., Franks, J. J., and Lewis, B., 1975, Cancer procoagulant A: A factor X activating procoagulant from malignant tissue. Thrombosis Research, 6, 127–137.

    Google Scholar 

  23. Harker, L. A., and Slighter, S. J., 1972, Platelet and fibrinogen consumption in man. New England Journal of Medicine, 287, 999–1005.

    Google Scholar 

  24. Honk, K. V., 1982, Prostacyclin/thromboxane ratios in tumor growth and metastasis. Prostaglandins and Cancer, edited by T. J. Powles, R. S. Bockman, K. V. Honn and P. W. Ramwell (New York: Alan Liss, Inc.), p. 733.

    Google Scholar 

  25. Honn, K. V., Cigone, B., and Skoff, A., 1981, Prostacyclin: a potent antimetastatic agent. Science, 212, 1270–1272.

    Google Scholar 

  26. Karpatkin, S., Smerling, A., and Pearlstein, E., 1980, Plasma requirement for the aggregation of rabbit platelets by an aggregating material derived from SV40-transformed 3T3 fibroblasts. Journal of Laboratory and Clinical Medicine, 96, 994–1001.

    Google Scholar 

  27. Kramer, R. H., and Nicolson, G. L., 1979, Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. Proceedings of the National Academy of Sciences of the United States of America, 76, 5704–5708.

    Google Scholar 

  28. Lione, A., and Bosmann, H. B., 1978, The inhibitory effect of heparin and warfarin treatments on the intravascular survival of B16 melanoma cells in syngeneic C57 mice. Cell Biology, International Report, 2, 81–86.

    Google Scholar 

  29. Maat, B., and Hilgard, P., 1981, Anticoagulant and experimental metastases — evaluation of antimetastatic effects in different model systems. Journal of Cancer Research Clinical Oncology, 101, 275–283.

    Google Scholar 

  30. Menter, D., Neagos, G., Dunn, J. R., Palazzo, R., Tchen, T. T., Taylor, J. D., and Honn, K. V., 1982, Tumor cell induced platelet aggregation: inhibition by prostacyclin, thromboxane A2 and phosphodiesterase inhibitors. Prostaglandins and Cancer, edited by T. J. Powles, R. S. Bockman, K. V. Honn and P. W. Ramwell (New York: Alan Liss), p. 809.

    Google Scholar 

  31. Moncada, S., and Vane, J. R., 1977, The discovery of prostacyclin—a fresh insight into arachidonic acid metabolism. Biochemical Aspects of Prostaglandin and Thromboxane Research, edited by N. Kharasch and J. Fried (New York: Academic Press), pp. 155–177.

    Google Scholar 

  32. Pearlstein, E., Amrrogio, L., Gasic, G., and Karpatkin, S., 1981, Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl) amide. Cancer Research, 41, 4535–4539.

    Google Scholar 

  33. Pearlstein, E., Cooper, L. B., and Karpatkin, S., 1979, Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialvlation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Journal of Laboratory and Clinical Medicine, 93, 332–244.

    Google Scholar 

  34. Pearlstein, E., Salk, P. L., Yogeeswaran, G., and Karpatkin, S., 1980, Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proceedings of the National Academy of Science of the United States of America, 77, 4336–4339.

    Google Scholar 

  35. Roos, E., and Dingemans, K. S., 1979, Mechanisms of metastasis. Biochimica et biophysica acta, 560, 135–166.

    Google Scholar 

  36. Salmon, J. A., Smith, D. R., Flower, R. J., Moncada, S., and Vane, J. R., 1978, Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. Biochimica et biophysica acta, 523, 250–262.

    Google Scholar 

  37. Seuter, F., Busse, W. D., Meng, K., Hosmeister, F., Moller, E., and Horstmann, H., 1979, The antithrombotic activity of Bay g 6576. Arzneim-Forschung/Drug Research, 29, 54–59.

    Google Scholar 

  38. Skolnik, G., Alpsten, M., and Ivarsson, L., 1980, Studies on mechanisms involved in metastatis formation from circulating tumor cells. Journal of Cancer Research and Clinical Oncology, 97, 249–256.

    Google Scholar 

  39. Sloane, B. F., Dunn, J. R., and Honn, K. V., 1981, Lysosomal cathepsin B: correlation with metastatic potential. Science, 212, 1151–1153.

    Google Scholar 

  40. Smith, J. B., 1980, The prostanoids in hemostasis and thrombosis. American Journal of Pathology, 99, 743–804.

    Google Scholar 

  41. Vargaftig, B. B., Chignard, M., and Benveniste, J., 1981, Present concepts on the mechanism of platelet aggregation. Biochemical Pharmacology, 30, 263–271.

    Google Scholar 

  42. Vermylen, J., Chamone, D. A. F., and Verstraete, M., 1979, Stimulation of prostacyclin release from vessel wall by Bay g 6575. Lancet, 1, 518–520.

    Google Scholar 

  43. Warren, B. A., and Vales, O., 1972, The adhesion of thromboplastic tumour emboli to vessel walls in vivo. Journal of Experimental Pathology, 53, 301–313.

    Google Scholar 

  44. Weiss, S. J., Turk, J., and Needleman, P., 1979, A mechanism for the hydroperoxide mediated inactivation of prostacyclin synthetase. Blood, 53, 1191–1196.

    Google Scholar 

  45. Wood, S., 1971, Mechanisms of establishment of tumor metastases, Pathobiology Annual, Volume 1, edited by H. L. Ioachim (London: Butterworths), p. 281.

    Google Scholar 

  46. Yoshimoto, T., Yamamoto, S., and Hayaishi, V., 1978, Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkyl-imidazoles. Prostaglandins, 16, 529–540.

    Google Scholar 

  47. Zacharski, L. R., Henderson, W. G., Rickles, F. R., Forman, W. B., Cornell, Jr., C. J., Forcier, R. J., Harrower, H. W., and Johnson, R. O., 1979, Platelets and malignancy: rationale and experimental design for the VA cooperative study of RA-233 in the treatment of cancer. Cancer, 44, 732–741.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Radiation Oncology, Radiology and Biological Sciences, Wayne State University, 48202, Detroit, MI, U.S.A.

    Kenneth V. Honk

Authors
  1. Kenneth V. Honk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Honk, K.V. Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. Clin Exp Metast 1, 103–114 (1983). https://doi.org/10.1007/BF00121490

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00121490

Keywords

Search

Navigation